Medical Countermeasures Nanoparticle Anthrax Vaccine Shows Promise in Enhancing Biodefense PreparednessGlobal Biodefense StaffSeptember 9, 2025
Medical Countermeasures New Mutation and DNA Repeats Behind Ceftazidime Resistance in Melioidosis BacteriumGlobal Biodefense StaffSeptember 5, 2025
Medical Countermeasures Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia VaccineGlobal Biodefense StaffAugust 11, 2025
Phase I Study Planned for Multivalent Vaccine to Combat Ebola, Marburg Industry News September 12, 2016 …
Malaria Box, Pathogen Box Revolutionize Open Source Drug Development Medical Countermeasures July 28, 2016 …
